EDITORIAL
Published on 20 Jun 2023
Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer, Volume II
doi 10.3389/fonc.2023.1218855
- 924 views
- 1 citation
- Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target in Cancer - Volume II
Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target in Cancer - Volume II
3,050
Total Downloads
9,680
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 22 Mar 2023
Clinical efficacy of laparoscopic radical hepatectomy and laparotomy for hepatocellular carcinoma and factors of postoperative recurrence
doi 10.3389/fonc.2023.1116984
- 779 views
- 1 citation
ORIGINAL RESEARCH
Published on 07 Mar 2023
Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma
doi 10.3389/fonc.2023.1128785
- 1,364 views
- 2 citations
ORIGINAL RESEARCH
Published on 02 Mar 2023
Integrating network pharmacology prediction and experimental investigation to verify ginkgetin anti-invasion and metastasis of human lung adenocarcinoma cells via the Akt/GSK-3β/Snail and Wnt/β-catenin pathway
doi 10.3389/fphar.2023.1135601
- 1,522 views
- 7 citations
ORIGINAL RESEARCH
Published on 09 Feb 2023
RNF6 activates TGF-β1/c-Myb pathway to promote EMT in esophageal squamous cell carcinoma
doi 10.3389/fonc.2023.1081333
- 1,040 views
- 2 citations
ORIGINAL RESEARCH
Published on 06 Jan 2023
Atractylenolide I inhibits EMT and enhances the antitumor effect of cabozantinib in prostate cancer via targeting Hsp27
doi 10.3389/fonc.2022.1084884
- 1,156 views
- 8 citations
Published in
Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore
Impact
- 9,680Topic views
- 5,580Article views
- 3,050Article downloads